Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

G-CSF (Filgrastim) or Pegfilgrastim Secondary Prophylaxis In The Adjuvant Chemotherapy Of Early Breast Cancer

NCT00030758 is registered in ClinicalTrials.gov with Anglo Celtic Cooperative Oncology Group as lead sponsor.

NCT NCT00030758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00030758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
G-CSF (Filgrastim) or Pegfilgrastim Secondary Prophylaxis In The Adjuvant Chemotherapy Of Early Breast Cancer
Lead sponsor
Anglo Celtic Cooperative Oncology Group
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2001
Completion date
Not reported
Enrollment
816 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neutropenia